Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation

Published:2011-08-04 Issue:11 Volume:87 Page:1126-1134
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

Bertelsen Lotte B.,Shen Yuan Yuan,Nielsen Thomas,Stødkilde-Jørgensen Hans,Kenneth Lloyd G.,Siemann Dietmar W.,Horsman Michael R.

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

http://www.tandfonline.com/doi/pdf/10.3109/09553002.2011.605418

Reference43 articles.

1. Intravascular contrast agent–enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor

2. The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic study of leukopenia treatment by Qijiao shengbai Capsule via the Bcl2/Bax/CASAPSE3 pathway;Frontiers in Pharmacology;2024-09-04

2. Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study;Lung Cancer;2024-09

3. 2,5-Diketopiperazines (DKPs): Promising Scaffolds for Anticancer Agents;Current Pharmaceutical Design;2024-03

4. Development and Validation of a Novel UHPLC-MS/MS Method for the Quantification of Plinabulin in Plasma and Its Application in a Pharmacokinetic Study with Leukopenic Rats;Pharmaceuticals;2023-08-14

5. Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect;Advanced Drug Delivery Reviews;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3